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c-Src is a non-receptor tyrosine kinase involved in numerous signal transduction pathways. The kinase,
SH3 and SH2 domains of c-Src are attached to the membrane-anchoring SH4 domain through the flexible
Unique domain. Here we show intra- and intermolecular interactions involving the Unique and SH3
domains suggesting the presence of a previously unrecognized additional regulation layer in c-Src. We have
characterized lipid binding by the Unique and SH3 domains, their intramolecular interaction and its
allosteric modulation by a SH3-binding peptide or by Calcium-loaded calmodulin binding to the Unique
domain. We also show reduced lipid binding following phosphorylation at conserved sites of the Unique
domain. Finally, we show that injection of full-length c-Src with mutations that abolish lipid binding by the
Unique domain causes a strong in vivo phenotype distinct from that of wild-type c-Src in a Xenopus oocyte
model system, confirming the functional role of the Unique domain in c-Src regulation.
C
-Src is the leading member of the Src family of non-receptor tyrosine kinases (SFKs) involved in many
signaling pathways1–5. The SH3, SH2 and kinase domains of SFK members display large sequence and
structural similarity. They also have in common amyristoylated and/or palmitoylatedmembrane anchor-
ing region in the N-terminus, including positively charged residues (Arg and/or Lys), known as the SH4
domain6,7. In contrast, the segment connecting the SH3 and SH4 domains, known as theUnique domain, presents
unique sequences for each SFKs protein and is intrinsically disordered.With few exceptions, no clear function has
been assigned to the Unique domains of SFKs8–11. However, swapping the Unique domains of c-Src and c-Yes
results in a change in their specificity12,13. Previous studies indicate that, in addition to the SH4 domain, further
regions in the first 111 amino acids are involved in membrane anchoring. Indeed, removal of more than 8 kDa
from the amino terminus of c-Src failed to detach the protein from membranes and a c-Src mutant lacking
residues 8 to 37 still binds to membranes14–16.
The N-terminal region of c-Src, including the SH4 and Unique domains, was found by NMR to display a
partially structured section between residues 60–64 and 67–7417. Here we show that this region includes a new
lipid binding site, in addition to the SH4 domain, with affinity for acidic lipids andmodulated by phosphorylation
of neighbor serine and threonine residues, by binding to calcium-bound calmodulin or by interaction with the
adjacent SH3 domain. We further show, for the first time, that the SH3 domain of c-Src contains also a lipid
binding region in the opposite side of its peptide binding site. The functional relevance of the partially structured
region of the Unique domain has been demonstrated in the Xenopus laevis oocyte model system.
Together, these results reveal an important functional role for the Unique domain of c-Src and suggest the
existence of a previously unrecognized regulation layer in c-Src and, possibly, other related SFKs. The complex
regulation of c-Src is consistent with its role as a hub connecting many different signaling pathways.
Results
Lipid binding by the Unique domain of c-Src.A15N-labelled construct containing residues 1–85 of c-Src (USrc)
was studied by NMR in the presence of bicelles containing variable proportions of dimyristoyl phosphatidyl
choline (DMPC) and the acidic lipid dimyristoyl phosphatidyl glycerol (DMPG). Bicelles are small disk-like
SUBJECT AREAS:
SOLUTION-STATE NMR
ONCOGENES
INTRINSICALLY DISORDERED
PROTEINS
MECHANISM OF ACTION
Received
17 December 2012
Accepted
1 February 2013
Published
18 February 2013
Correspondence and
requests for materials
should be addressed to
M.P. (mpons@ub.edu)
*Current address:
IQAC-CSIC. NMR
Facility, Jordi-Girona
18-26, 08034
Barcelona, Spain.
SCIENTIFIC REPORTS | 3 : 1295 | DOI: 10.1038/srep01295 1
structures formed by planar bilayers of long-chain lipids closed by
highly curved, micelle-like walls formed essentially by short chain
lipids (dihexanoyl phosphatidylcholine, DHPC). These model
membranes have been previously used to study protein-lipid
interactions18–20. An expansion of the 1H-15N HSQC NMR spectra
of USrc in the absence or presence of lipids and a plot of the lipid-
induced shift changes in each residue are shown inFigures 1a and 1b,
respectively. Significant shifts were observed in two regions: the
N-terminal SH4 domain and residues S51, A53, A55, and
60EPKLFGGF67 of the Unique domain. The observed shifts in the
Unique domain region were larger than those observed in the well
known lipid binding SH4 domain. The 60–67 segment is included in
the partially structured region (60–75) previously determined by
NMR17 and we refer to it as the Unique Lipid Binding Region
(ULBR). The SH4 domain and the ULBR showed affinity for
negatively charged lipids. However, in contrast to residues in the
SH4 domain, the ULBR was also substantially perturbed by neutral
lipid bicelles. The specificity for different lipid classes was tested
using Lipid-StripsTM. USrc binds preferentially to acidic lipids,
namely phosphatidic acid (PA), cardiolipin (CL), phosphati-
dylserine (PS), phosphatidylinositol-4-phosphate (PtdIns(4)P), and
phosphatidylinositol-3,4,5-triphosphate (PtdIns(3,4,5)P3) (Fig. 1c).
Lipid binding by SH3 domain of c-Src. We next investigated
lipid binding by the Unique domain attached to the SH3
domain (Fig. 2a,b) (USH3, residues 1–150) and the isolated SH3
domain (Fig. 2c,d) (SH3, residues 86–150). The effect of lipids
in the isolated or SH3-bound Unique domain were very similar.
However, large lipid-induced shifts were also observed for residues
98–102 and 114–116 of c-Src SH3 both in the USH3 construct
(Fig. 2a) and in isolated SH3 domain (Fig. 2d). These residues are
located in the opposite face to the one containing the canonical
peptide binding site of the SH3 domain (Fig. 2e). Lipid binding by
the isolated SH3 domain was also observed using Lipid-StripsTM and
showed a similar lipid selectivity than the Unique domain (Fig. 2c).
However, the USH3 construct, where the two domains are
simultaneously present, did not bind phosphoinositides (PIPs)
although it could still bind to other acidic lipids (Fig. 2b). The
changes in lipid selectivity of the two-domain construct with
respect to the isolated domains suggest the two domains are
interacting.
Interaction between the Unique and SH3 domains of c-Src. In
order to test for inter-domain interactions we compared the
chemical shifts of equivalent residues in the USH3, USrc and
SH3 constructs. Representative HSQC NMR spectra are given in
Supplementary Figure 1. Chemical shift changes between isolated
and linked domains are shown in Figures 3a,b. Significant shifts were
observed for H25, T37, H47, A55, N68, a region overlapping with the
ULBR (Unique domain), and residues 98–103, 114–116, 134, and
145 (SH3 domain). The SH3 residues belong to the conserved RT
(98–103) and nSrc (114–116) loops (Fig. 3d). Some of these residues
(R98, E100, D102, L103, Y134) and S97 experienced small chemical
shift changes when USrc was added to the isolated domain
(Supplementary Fig. 2) confirming that the interaction could
occur, even when the two domains are not linked.
Figure 1 | Lipid binding by the Unique domain of c-Src (a) Overlay of 1H-15N HSQC NMR spectra USrc alone (red) and in the presence of
DMPC/DHPC bicelles (blue), and DMPG/DHPC bicelles (grey). (b) Combined 1H-15N lipid-induced chemical shift changes per residue. The color code
is the same as in (a). Total lipid concentration was 8% w/v and the ratio of long chain lipids to DHPC (q) was 0.8. (c) Binding of USrc to immobilized
lipids, detected by immunoblotting with anti-Strep-tag HRP (TG triglyceride, DAC diacylglyceride, PA phosphatidic acid, PS phosphatidylserine,
PE phosphatidylethanolamine, PC phosphatidylcholine, PG phosphatidylglycerol, CL cardiolipin, PtdIns phosphatidylinositol). (d) Schematic
representation of the structure and charge of the lipid bicelles used.
www.nature.com/scientificreports
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The mapping of the interacting residues was confirmed by
Paramagnetic Relaxation Enhancement (PRE) induced by (1-oxy-
2,2,5,5-tetramethyl-D-pyrroline-3-methyl)-methanethiosulfonate
(MTSL) linked to a cysteine residue introduced by site specific muta-
genesis at position 59. NMR signals from nuclei that are, even tran-
siently, close to the paramagnetic centre (Fig. 3e) are broader and
less intense than the equivalent peaks from diamagnetic controls.
Figure 3c shows the ratio of intensities of NH signals between para-
magnetic and diamagnetic forms, plotted along the protein sequence.
The clusters of residues in c-Src SH3 most affected by the para-
magnetic probe in residue 59 of the Unique domain matched those
showing the largest chemical shift changes between SH3 and USH3
(cf. marked regions in Figs. 3b and 3c). This result also confirmed
that A59 is close to the interacting region.
TheUnique-SH3 interaction is allosterically prevented by binding
of a polyproline peptide to the SH3 domain. The SH3 domain of c-
Src binds peptides containing the Pro-X-X-Pro motif in a polypro-
line II helix21. We investigated by NMR the effect of binding of a
consensus high affinity unlabelled SH3 peptide ligand (Ac-
VSLARRPLPPLP-OH) on the interaction between the Unique and
SH3 domains in15N-labeled USH3. Figures 4a–e show expansions of
NMR spectra including signals from theNHgroup of A55 and a non-
perturbed residue (E150) in the presence of increasing amounts of
peptide. In the presence of substoichiometric amounts of peptide,
the A55 residue appeared duplicated and the relative intensities of
the two peaks changed during the titration. This behavior is
characteristic of slow exchange in the NMR time scale between
peptide-bound and free USH3. The chemical shifts of NH groups
in the Unique domain of peptide-bound USH3 matched those of the
isolated Unique domain (Fig. 4f), indicating that peptide binding to
the SH3 domain abolished its interaction with the Unique domain.
The SH3 residues that interact with the Unique domain are located
on the opposite side of the SH3 domain where polyproline ligands
bind, and therefore the loss of the interaction between the Unique
and SH3 domain is not the result of direct competition with the
peptide but an allosteric effect (Fig. 4g).
Modulation of lipid binding by phosphorylation. USrc was
monophosphorylated at S17 using PKA or diphosphorylated at
T37 and S75 positions with GST-Cdk5 activated with GST-p25 as
previously described17. Figure 5 compares the lipid-induced NMR
chemical shift perturbations in phosphorylated and unphosphory-
lated forms of USrc. Phosphorylation at S17 almost abolished
the interaction with lipids of the SH4 region, as seen by the signi-
ficant decrease in lipid-induced NMR shifts but had only a moderate
effect on the ULBR (Fig. 5a). Conversely, phosphorylation of S37/
T75 caused a significant reduction in lipid binding by the ULBR with
minor effects on the lipid interaction by the SH4 domain (Fig. 5b).
The effects observed in residues distant from the phosphorylation
sites suggest the two lipid binding regions show some degree of
binding cooperativity. In previous work we had demonstrated that
phosphorylation of S17, S37 and T75 has only local effects and does
no induce structural perturbations in isolated USrc17. Therefore, we
suggest that phosphorylation destabilizes electrostatically the inte-
raction of the Unique domain of c-Src with acidic lipids.
Figure 2 | Lipid binding by Unique-SH3 (USH3) and isolated SH3 domains. Lipid binding by the USH3 construct (a, b) and the isolated SH3 domain
(c,d,e). (a, d)) Combined 1H-15N chemical shift perturbations induced by the presence of 8%w/v of DMPG/DHPC bicelles (q5 0.8). (b,c) Immunoblots
showing the lipid binding specificity (see Fig. 1c for the identity of the lipids and to compare with the isolated Unique domain). (e) Residues perturbed in
presence of lipids are highlighted in yellow on the SH3 surface (PDB code: 1SHG). The polyproline binding site is located in the opposite side and
indicated by the presence of a polyproline ligand.
www.nature.com/scientificreports
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Calmodulin modulates lipid binding by the Unique domain of
c-Src. The interaction of some disordered proteins with lipids is
modulated by calcium levels through binding to calmodulin22,23.
The effect of adding calcium-loaded calmodulin (CaM) to USrc is
shown in Figure 6. Remarkably, chemical shift changes and/
or broadening were observed for a number of residues in the
Unique domain. The largest changes were observed for residues
A44, S51, A55, F64, and G65, partially overlapping with the ULBR
(Fig. 6c).
No changes were observed when apo-calmodulin and calcium
were added independently or when CaM was added to the isolated
SH3 domain (results not shown). Instead, after addition of CaM to
the Unique-SH3 construct, chemical shifts changes were observed
for SH3 residues 97SRTETDL103 (in the RT-loop) and 133GYI135, which
correspond to a subset of those perturbed by the interaction with the
Unique domain (Supplementary Fig. 3a,b and d). The effect of
adding CaM to the USH3 construct was to return the chemical shifts
of these residues to values typical of the free SH3 domain. We con-
Figure 3 | Interaction between Unique and SH3 domains (a,b) Combined absolute values 1H-15N NMR chemical shift differences between linked and
isolated domains. (a) USH3 versus USrc. (b) USH3 versus SH3. (c) Intensity ratios of NH cross-peaks from MTLS-labeled (A59C/USH3 at pH 7.0)
between paramagnetic and diamagnetic (DTT reduced) forms. (d) SH3 residues perturbed by interaction with the Unique domain are highlighted in
orange. The polyproline binding site is located in the opposite site and indicated by the presence of a polyproline ligand. (e) Cartoon representation of the
interaction between SH3 and Unique domains observed by PRE.
Figure 4 | Allosteric effect of polyproline peptide binding on the Unique-SH3 interaction. (a–e) Expansion of HSQC spectra showing residues A55 and
E150 (acting as control) at molar rations of the Unique-SH3 construct (USH3) to Ac-VSLARRPLPPLP-OH of (a) 0, (b) 0.2, (c) 0.4, (d) 0.7, and (e) 1.0.
(f) Expansion of HSQC spectrum of the isolated Unique domain (USrc) containing residue A55. All spectra were recorded at 25uC and 800 MHz.
(g) Cartoon representation depicting the fact that he fast equilibrium between the open-close interaction between the Unique and SH3 domains is
cancelled by the interaction of a polyproline (PP) peptide with the SH3 domain in spite of the fact that the two binding sites are separated.
www.nature.com/scientificreports
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clude that calmodulin binds to the Unique domain of c-Src and this
interaction competes with the intra-molecular interaction with the
SH3 domain. However, the chemical shifts of SH3 residues
113IVNN116 in the nSrc loop, which also interact with the Unique
domain, remained unaffected in presence of CaM, indicating that
this region of the SH3 domain is still interacting with the Unique
domain, even when it is bound to calmodulin.
The effect of CaMon lipid binding by theUSH3 construct was also
tested using Lipid-StripsTM (Supplementary Fig. 3c). The addition of
a five-fold excess of CaM drastically reduced the capacity of USH3 to
bind lipids. This effect is mediated by the Unique domain as CaM
had no effect on the lipid interactions of the isolated SH3 domain.
In vivo effects of mutations in the Lipid Binding Region of the
Unique domain. Xenopus laevis oocytes were used as model system
to test the effect of mutations of the ULBR in the context of full-
length c-Src. The ULBR and phosphorylation sites shown to be
relevant for Unique domain interactions are highly conserved even
in phylogenetically distant species (Fig. 7). A charge-conserving
mutant was generated by replacing residues 63–65 (LFG) by
63AAA65 (mutant AAA). A second mutant had residues 63–68 of
c-Src (LFGGFN) replaced by 63AAAEAE68 (mutant EAE), where
the additional mutations and the extra negative charges were
expected to completely abolish lipid binding. Indeed, addition of
lipids did not perturb the NMR chemical shifts of Unique domain
residues of the EAE mutant and had only a small effect on Unique
domain of the AAA mutant. Lipid binding by the SH4 domain was
still observed in both mutants (Supplementary Fig. 4).
Progesterone induced maturation of Xenopus oocytes has been
previously shown to be accelerated by the expression of constitutively
active viral or Xenopus Src24. Oocytes were injected with in vitro
transcribedmRNAs encoding constitutively active human c-Src pro-
tein, with either wild-type, AAA, or EAEUnique domains. Figure 8a
shows the percentage of oocytes that completed maturation at dif-
ferent times after the addition of progesterone. Maturation was
assessed by the appearance of a white spot at the animal pole of
the oocytes, which indicates germinal vesicle breakdown (GVBD)
and meiosis I entry. Oocytes injected with mRNA encoding wild-
type c-Src started maturation around 2 h before control oocytes,
either untreated or injected with H2O. This observation agrees with
previous reports25 and confirms that Xenopus oocytes are an appro-
priate model to functionally characterize human c-Src. Interestingly,
Figure 5 | Effect of phosphorylation on lipid binding byUSrc. Combined
1H-15N NMR shifts induced by DMPG/DHPC bicelles (8% w/v total lipid
concentration, q 5 0.8) in USrc unphosphorylated (a,b, gray),
monophosphorylated at S17 (a, blue), and diphosphorylated at T37 and
S75 (b, blue).
Figure 6 | Calmodulin binding by the Unique domain of c-Src. Two
different expansions of 1H-15N HSQC NMR spectra obtained during the
titration of USrc with Ca21-calmodulin (CaM) are shown in panels a and b.
(c) Combined absolute values of 1H-15N chemical shift changes induced by
2-fold excess of Ca21-calmodulin in USrc residues.
www.nature.com/scientificreports
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oocytes injected with mRNAs encoding the AAA or EAE Unique
domain mutants also showed accelerated maturation in response to
progesterone but only around 70%–80% completed the process
(Figure 8a, inset). In addition, 2 h after the appearance of the white
spot, about half of the matured oocytes that expressed AAA or EAE
mutants showed progressive depigmentation and started to die
(Fig. 8b). These effects were not a consequence of different express-
ion levels of the wild type and mutant forms of c-Src as all three
proteins were expressed at similar levels in the injected oocytes
(Fig. 8c).
Discussion
The regulation of c-Src has been extensively studied. Known
mechanisms implicate the kinase (SH1), SH2, SH3 and SH4 domains
and the C-terminal regulatory tail. The regulatory processes involve,
among others, the phosphorylation of tyrosine residues in the C-tail
and kinase domain, and the recognition of peptidemotifs by SH2 and
SH3 domains. Palmitoylation and/or myristoylation of the SH4
domain mediate localization and anchoring to membrane surfaces
that also modulates the activity of other kinases of the Src family. c-
Src has only a single myristoyl group. The role of the intrinsically
disordered Unique domain connecting the SH4 and SH3 domains is
poorly understood, although some earlier reports have suggested that
it may participate in c-Src function and regulation11–13. In this article,
we show that the Unique domain and the SH3 domains of c-Src
participate in a number of intra- and intermolecular interactions
suggesting the existence of a new regulation layer in c-Src and pos-
sibly in other members of the c-Src family.
We demonstrate, for the first time, that human c-Src has at least
two additional lipid binding regions in addition to the SH4 domain
that show specificity for acidic lipids, including phosphoinositides.
One of them is located in the intrinsically disordered Unique domain
and includes residues 51, 53, 55, and 60 to 67 (the Unique Lipid
Binding Region - ULBR). The second one includes residues in the
RT and nSrc loops of the SH3 domain.
Previous examples of lipid binding by SH3 domains are restricted
to helical extended specialized SH3 domains, (hSH3), reported to
bind acidic phospholipids26,27. These specialized hSH3 domains
Figure 7 | Sequence alignment of the Unique domain of Src. Sequence alignment of the Unique domains of human, mouse, chicken and Xenopus laevis
Src is shown. Green boxes highlight residues S17, T37 and S75 that are known to be phosphorylated in vitro. Orange box shows the position of the 6
aminoacids of the ULBR that were mutated in the oocytes maturation experiment (see Fig. 8).
Figure 8 | Effect of Src mutants on Xenopus oocyte maturation. The effect of the injection of oocytes with mRNAs encoding wild-type c-Src (green),
AAA mutant (blue), EAE mutant (magenta), or water (orange) is compared with that of non-injected oocytes (yellow). (a) Percentage of oocytes
that underwentmaturation, as determined germinal vesicle breakdown (GVBD), at different times after the addition of progesterone. The inset shows the
percentages ofmorphologically normal oocytes at the end of the experiment, when 100%of the control oocytes treated with progesterone reachedGVBD.
(b) Oocyte appearance 2 and 4 h after GVBD. About half of the matured oocytes that express AAA or EAE mutants show progressive depigmentation
starting 2 h after GVBD. (c) Analysis of the expression levels of wild-type and mutants forms of human c-Src and endogenous Xenopus c-Src. Oocyte
lysates were separated by SDS-PAGE and analyzed by immunoblotting with anti-human c-Src (top panel), anti-Xenopus c-Src (middle panel) and
anti-MPK1 (bottom panel) as a loading control.
www.nature.com/scientificreports
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display a strongly positively charged surface and lipid binding
requires an extra helical domain docked on the domain core. In
contrast, lipid binding by c-Src SH3 takes place in the absence of
an extended helical region. Previously, PtdIns(3,4,5)P3 binding by
the c-Src SH2 domain had been reported28.
Lipid binding outside the SH4 domain suggests a more complex
interplay of c-Src with the membranes to which is anchored through
the myristoylated domain. Importantly, lipid binding through resi-
dues 60-75 of the flexibleUnique domainwould result in a significant
decrease of the distance the folded core of the protein can reach away
from the membrane surface and, therefore, a change in the ligands
or substrates that are accessible to these domains. The possible rel-
evance of such a ‘‘positional regulation’’ mechanism is stressed by the
discovery of, at least, two additional regulatory mechanisms that
modulate the interaction of the Unique domain with lipids. The first
one is phosphorylation of T37/S75 and S17 in the Unique domain,
that decreases affinity for acidic phospholipids. The same phosphor-
ylation events have previously been associated to physiological pro-
cesses. Phosphorylation of S17 is required for cAMP activation of
Rap1, inhibition of extracellular signal-regulated kinases, and inhibi-
tion of cell growth, although no mechanism was proposed29. T34,
T46 and S72 in chicken c-Src (corresponding to T37 and S75 in
human c-Src; T46 is not conserved) are phosphorylated by Cyclin
dependent-kinase 1 (Cdk1) duringmitosis, whereas Cdk5 is respons-
ible for mitosis independent phosphorylation of S75 in human Y79
retinoblastoma cells30.
A second modulation mechanism of the Unique-lipid and
Unique-SH3 interactions involves binding of calcium-loaded calmo-
dulin to the Unique domain, which suppresses lipid binding by
the isolated Unique domain as well as by the USH3 construct and
modulates the interaction between the SH3 and Unique domains.
However, apo-calmodulin showed no interactions with either
domain. Therefore, interactions involving the Unique domain of
c-Src may be modulated by calcium levels through calmodulin.
A similar modulation of phosphoinositides binding by CaM has
been suggested for another class of myristoylated, intrinsically dis-
ordered proteins: the myristoylated alanine-rich C-kinase substrates
(MARCKS) involved in binding to PtdIns(4,5)P223. In response to
increased calcium levels, CaM binding induces partial detachment of
MARCKS from the plasma membrane and release of PtdIns(4,5)P2
molecules sequestered by a basic lipid binding region of MARCKS,
thus increasing the levels of free inositides. The protein may remain
attached to themembrane through themyristoyl group. The fact that
the Unique domain of c-Src is also myristoylated, disordered, and
capable of phosphoinositide binding, suggests that a similar mech-
anism may be operative in this case.
Phosphoinositide phosphates play a fundamental role in control-
ling membrane-cytosol interfaces and constitute signals that help
define organelle identity31. PtdIns(4)P and PtdIns(3,4,5)P3 are con-
centrated in the plasma membrane and possibly enriched in raft-like
structures. PtdIns(3,4,5)P3 is present in negligible amounts in resting
cells but increases dramatically in response to growth factor stimu-
lation and mediates cell proliferation, migration, differentiation and
metabolic changes32,33. PtdIns(3,4,5)P3 recruits proteins involved in
the regulation of the actin cytoskeleton and mediates the effect of
growth factors on the formation of peripheral ruffles implicated in
cell migration34.
In addition to interacting with lipids, the Unique and SH3
domains of c-Src interact with each other, as seen by NMR. The
protein-protein interaction regions overlap with the lipid-binding
regions in both domains. The SH3 region interacting with the
Unique domain includes the RT and nSrc loops located opposite
to the classical peptide binding site. Peptide binding outside the
polyproline binding cleft had been previously observed in other
SH3 domains35. Also, the interaction of non-canonical peptidemotifs
in intrinsically disordered regions with SH3 domains was predicted36
and has been recently observed37 and simultaneous binding of pep-
tides at two sites of an SH3 domain has been reported38. However,
we have found that binding of a poly-proline peptide to the SH3
domain of c-Src allosterically inhibits its interaction with the
Unique domain. Previous NMR studies have shown that peptide
binding to the c-Src SH3 domain triggered a cascade of perturbations
along a chain of hydrogen bonds connecting the peptide binding
region with the RT and nSrc loops located on the opposite face of
the domain39. Interestingly, in the inactive basal state of c-Src the SH3
domain interacts with the polyproline linker region connecting the
SH2 and kinase domains. This interaction is released when c-Src is
activated40,41. Since the lipid and protein binding regions in both SH3
and Unique domains overlap, our results suggest that the activation
state of c-Src may affect lipid binding by the Unique/SH3 domains
and provides a connection between a ‘‘classical’’ regulation mech-
anism (polyproline recognition by the SH3 domain) and a new
regulatory layer, involving lipid binding by the Unique and SH3
domains.
We have demonstrated the biological relevance of the interactions
involving the ULBR in the context of full length c-Src, by comparing
the effects of proteins with wild type or mutated ULBR sequences
in the maturation of Xenopus laevis oocytes, used as a model system.
The motif present in the ULBR formed by the sequence FGG
(F/V) followed by a stretch of small polar residues (N/D/S/T) is
highly conserved in c-Src of a range of species including Xenopus
laevis. TheULBRmotif is also present in theUnique domain of c-Fyn
and c-Yes, the two kinases most similar to c-Src. Injection of mRNA
encoding a constitutively active form of human c-Src caused an
acceleration of progesterone-induced maturation of oocytes, which
is very similar to that induced by constitutively active Xenopus c-Src
or v-Src24,25. This result validates the heterologous model. However,
injection of in vitro transcribed mRNAs encoding for mutants in
the ULBR caused that a significant portion (20%–25%) of the
oocytes failed to mature after treatment with progesterone. In addi-
tion, about half of the oocytes that matured, showed depigmentation
and possible apoptotic symptoms. Thus, while wild-type andmutant
forms of human c-Src are similarly active in the initiation of oocyte
maturation, the failure to complete maturation and the lethal pheno-
type observed only in matured oocytes expressing mutated c-Src
demonstrates that the ULBR plays an essential role in the regulation
of c-Src.
These results constitute a proof of concept of the functional
importance of the ULBR and support the idea that the observed
interactions are indeed part of a new level of regulation for c-Src.
Given the large number of interactions potentially involving the
Unique domain of c-Src, much work is still needed to elucidate the
details of the regulation mechanisms in which it may be involved.
Considering that c-Src is attached to membrane surfaces by its myr-
istoylated SH4 domain, an intriguing possibility would be that sec-
ondary lipid binding by the Unique and SH3 domains limits the sites
accessible to the kinase and SH2 domains, to those that are located
closer to the maximum separation from the membrane surface
allowed by the Unique domain. Thus, the effective length spanned
by the flexible Unique domain may introduce a certain degree of
compartimentalization in the direction perpendicular to the plane
of the membrane that could prevent the interaction between c-Src
and other proteins, even if they are attached next to each other on the
membrane. Modulation of the lipid-ULBR interaction could provide
a mechanism to change the effective length of the Unique domain
that connects the folded domains of c-Src to the membrane, and
therefore, the specificity of c-Src with respect to upstream and down-
stream signaling partners. Our group is actively investigating this
and alternative models of c-Src regulation involving the Unique
domain. The presence of this additional regulatory layer may help
to understand how c-Src effectively connects a wide variety of
upstream and downstream effectors.
www.nature.com/scientificreports
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Methods
Cloning and protein expression. The cDNA encoding (1–85) human c-Src region
with a Strep-tag in C-terminal position for purification purposes was cloned into a
pET-14b vector (Novagen, UK). Human USH3 protein (SH4, Unique and SH3
domains of c-Src protein, 1–150) or SH3 c-Src domain (86–150) were expressed as
His-GST fusion proteins using the pETM-30 vector (EMBL). Plasmids were
transformed in Escherichia coli RosettaTM (DE3)pLysS cells (Novagen, UK) and cells
were grown in M9 minimal medium supplemented with either [15N]NH4Cl, or
[15N]NH4Cl and D-[U-13C]-glucose (Cambridge Isotope Laboratories, UK).
USrc protein was isolated using Strep-tactin Sepharose (IBA, Go¨ttingen) and size
exclusion chromatography (Superdex 75 26/60, GE Healthcare, Spain). His-GST
proteins were purified using a Ni-NTA resin (Qiagen), cleaved from their fusion
partner with TEV protease (S219Vmutant with anN-terminal polyhistidine tag), and
re-purified with Ni-NTA resin and size exclusion chromatography. Mutations were
introduced using the QuickChange site-directed mutagenesis kit (Stratagene).
Preparation of bicelles. 12.5% (w/w) bicellar dispersions were prepared by mixing
long-chain (DMPCorDMPG) and short-chain (DHPC) phospholipids (Avanti Polar
Lipids, Alabaster, AL) in chloroform or chloroform/methanol, evaporating the
solvent and rehydrating the resulting lipid film in 50 mM phosphate buffer, pH 7.0.
The mixture was subjected to five freeze-thaw cycles with pipetting and vortexing
until the lipid solution was clear and transparent. The molar ratio of lipids in bicelle
samples was 1.0 DHPC50.4 DMPC50.1 DMPG (q5 0.5, 13.3% DMPGmolar ratio),
1.0 DHPC50.4 DMPC50.4 DMPG (q 5 0.8, 22.2% DMPG molar ratio),
1.0 DHPC50.8 DMPG (q 5 0.8, 44.4% DMPG molar ratio) and 1.0 DHPC50.8
DMPC (q5 0.8, 44.4%DMPCmolar ratio). DMPC1DMPG/DHPC (q ratios) of 0.5–
0.8 provide isotropic fast tumbling bicelles42,43. Concentrated protein solutions were
added to the bicelles to a final concentration of 0.2 mMprotein and 8% (w/v) of lipids.
NMR samples contained 10% D2O and 0.05% sodium azide and were measured at
298 K. Bicelle integrity was checked by 31P NMR and transmission electron
microscopy.
Protein-phospholipid assays. Lipid binding specificity was assessed with protein-
lipid overlay assays using commercially available lipid strips blotted with 100 pmol of
biologically relevant lipids (Echelon Biosciences), following manufacturer’s
instructions. Echelon Lipids StripsTM were blocked with 3% fatty acid-free BSA
(A7030, Sigma) in TBS-Tween for 1 h at room temperature and then incubated with
1 mM USrc, HisGST-USH3 or HisGST-SH3 (10 mg/ml, 47 mg/ml and 34 mg/ml,
respectively) in TBS-Tween for 1 h at room temperature. The membranes were
washed with TBS-Tween and incubated with a 153,000 dilution of anti-Streptag HRP
antibody (Novagen) or a 155,000 dilution of anti-Histag antibody (GEHealthcare) in
TBS-Tween for 1 h at room temperature. After washing, the membranes probed with
anti-His tag antibody were incubated with a 155,000 dilution of horseradish
peroxidase (HRP)-coupled anti-mouse IgG (GE Healthcare) for 1 h at room
temperature. After washing, protein-lipid interactions were detected by enhanced
chemiluminiscence (ECLTM detection, GE Healthcare).
Xenopus laevis oocytes. Xenopus laevis ovaries were surgically removed from
full-grown females and treated with collagenase and dispase. Stage VI oocytes were
then selected and cultured in Barth’s medium.
Wild type human c-Src cDNA or mutated variants in the Unique domain were
cloned in the vector FTX6. Constitutively active forms were obtained replacing
tyrosine 530 by phenylalanine. The different constructs were then used to prepare
mRNAs by in vitro transcription with the mMessage mMachine kit (Ambion).
Oocytes were microinjected with 50 nl of mRNAs (250 ng) and maintained
overnight in modified Barth’s medium at 18uC before progesterone stimulation
(5 mg/ml, Sigma) to induce maturation. For the preparation of lysates, oocytes were
homogenized in 10 ml per oocyte of ice-cold H1K buffer (80 mM
b-glycerophosphate, pH 7.5, 20 mM EGTA, 15 mM MgCl2, 1 mM DTT, 1 mM
AEBSF, 2.5 mM Benzamidine, and 10 mg/ml each of Aprotinin and Leupeptin).
Lysates were centrifuged at 10,0003 g for 10 min, and the cleared supernatants were
used for western blotting. Protocols are detailed in the review by Perdiguero and
Nebreda44. The following antibodies were used for western blotting: anti-Src [clone
327] (ab16885, Abcam), anti c-Src [SRC 2] (sc-18, Santa Cruz biotechnology),
anti-MPK1 (rabbit serum).
NMR Spectroscopy. NMR experiments were recorded in Bruker Avance 800 and
600 MHz spectrometers equipped with TCI cryo-probes at 0.2 mM protein
concentration in 50 mM phosphate buffer pH 7.0 at 298 K or 278 K. The lower
temperature allowed the observation of some NH signals from the Unique domain
that exchanged rapidly. Reported chemical shift differences are from spectra obtained
under identical conditions. Possible aggregation phenomena were ruled out by
comparing spectra recorded between 0.1 mM and 0.4 mM (Supplementary Fig. 5).
USrc assignments had been previously reported17 USH3 backbone assignments were
based on literature values (BMRB entries 3433 and 4888)45,46 measured at pH 6.5 and
confirmed with 3D triple-resonance proton-based experiments CBCANH,
CBCACONH and HNCO in a 0.6 mM 15N, 13C-double labelled USH3 sample
prepared in 50 mM sodium phosphate, 100 mM NaCl buffer (pH 6.5) containing
10% D2O. Assignments were transferred to other experimental conditions by
recording series of HSQC spectra at intermediate conditions.
Combined NH chemical shift differences were computed as in equation (1)
Dd~½Dd2Hz(DdN=5)21=2 ð1Þ
where DdH and DdN are the changes in chemical shift for 1H and 15N, respectively.
For PRE experiments the spin label (1-oxy-2,2,5,5-tetramethyl-D-pyrroline-3-
methyl)-methanethiosulfonate, MTSL, (Toronto Research Chemicals) was attached
as previously described to a cysteine residue introduced by mutation at position 5917.
Diamagnetic samples were measured after the paramagnetic sample by reducing the
paramagnetic tag with the addition of 5 mMDTT. PRE effects were determined as the
ratio of 1H-15NHSQC cross peak intensity, in the paramagnetic (Iox) and diamagnetic
(Ired) samples.
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